Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

MUHC study reveals no difference between mercury levels in autistic children and general population

07.05.2007
Researchers at The Montreal Children's Hospital (MCH) of the McGill University Health Centre (MUHC) have revealed new evidence dispelling the supposed link between mercury and autism.

The research team, led by Dr. Eric Fombonne, tested mercury levels in the hair and blood samples from autistic children and their mothers and found that the levels did not differ statistically from those samples taken from non-autistic children. They also demonstrated that there was no correlation between the mercury level and the severity of symptoms and level of functioning of autistic children. The results were announced today at the 6th International Meeting For Autism Research (IMFAR) held at the University of Washington State.

“In recent years, hypotheses have been raised concerning a possible relationship between mercury exposure and autism,” says Dr. Eric Fombonne principal researcher, Director of Pediatric Psychiatry at the MCH, and Head of the Division of Child Psychiatry at McGill. “Specifically, the concerns have been related to childhood thimerosal-containing vaccines, dental amalgams, and methylmercury in food.

“Our findings do not support the hypothesis that autism is a form of mercury poisoning. The mercury levels we discovered in autistic children and their mothers were within the normal range for the general population.”

Consecutive referrals of young children to the Autism Spectrum Disorders clinic at the MCH were invited to participate in the study. In total, 71 children were included in the study alongside 76 pediatric controls recruited from clinics at the same hospital. Children with autism spectrum disorders all met rigorous diagnostic criteria and were assessed with state-of-the-art standardized measures. Blood and hair samples were taken from all participating children and their mothers, and analyzed using the most advanced techniques available.

“An important practical implication of this study is that chelation therapies, whereby heavy metals are removed from the body using specific compounds , are not useful in the treatment of autism,” says Dr. Fombonne. “Chelation has never been proved efficacious as a biomedical intervention to treat autism.”

The Montreal Children’s Hospital is the pediatric teaching hospital of the McGill University Health Centre (MUHC). The institution is a leader in the care and treatment of sick infants, children, and adolescents from across Quebec. The Montreal Children’s Hospital provides a high level and broad scope of health care services, and provides ultra specialized care in many fields including: cardiology and cardiac surgery; neurology and neurosurgery, traumatology; genetic research; psychiatry and child development and musculoskeletal conditions, including orthopedics and rheumatology. Fully bilingual and multicultural, the institution respectfully serves an increasingly diverse community in more than 50 languages. www.thechildren.com

The Research Institute of the McGill University Health Centre (RI MUHC) is a world-renowned biomedical and health-care hospital research centre. Located in Montreal, Quebec, the institute is the research arm of the MUHC, a university health center affiliated with the Faculty of Medicine at McGill University. The institute supports over 500 researchers, nearly 1000 graduate and post-doctoral students and operates more than 300 laboratories devoted to a broad spectrum of fundamental and clinical research. The Research Institute operates at the forefront of knowledge, innovation and technology and is inextricably linked to the clinical programs of the MUHC, ensuring that patients benefit directly from the latest research-based knowledge. For further details visit: www.muhc.ca/research.

Seeta Ramdass | MUHC
Further information:
http://www.thechildren.com

More articles from Health and Medicine:

nachricht Study tracks inner workings of the brain with new biosensor
16.08.2018 | Rheinische Friedrich-Wilhelms-Universität Bonn

nachricht Foods of the future
15.08.2018 | Georg-August-Universität Göttingen

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Color effects from transparent 3D-printed nanostructures

New design tool automatically creates nanostructure 3D-print templates for user-given colors
Scientists present work at prestigious SIGGRAPH conference

Most of the objects we see are colored by pigments, but using pigments has disadvantages: such colors can fade, industrial pigments are often toxic, and...

Im Focus: Unraveling the nature of 'whistlers' from space in the lab

A new study sheds light on how ultralow frequency radio waves and plasmas interact

Scientists at the University of California, Los Angeles present new research on a curious cosmic phenomenon known as "whistlers" -- very low frequency packets...

Im Focus: New interactive machine learning tool makes car designs more aerodynamic

Scientists develop first tool to use machine learning methods to compute flow around interactively designable 3D objects. Tool will be presented at this year’s prestigious SIGGRAPH conference.

When engineers or designers want to test the aerodynamic properties of the newly designed shape of a car, airplane, or other object, they would normally model...

Im Focus: Robots as 'pump attendants': TU Graz develops robot-controlled rapid charging system for e-vehicles

Researchers from TU Graz and their industry partners have unveiled a world first: the prototype of a robot-controlled, high-speed combined charging system (CCS) for electric vehicles that enables series charging of cars in various parking positions.

Global demand for electric vehicles is forecast to rise sharply: by 2025, the number of new vehicle registrations is expected to reach 25 million per year....

Im Focus: The “TRiC” to folding actin

Proteins must be folded correctly to fulfill their molecular functions in cells. Molecular assistants called chaperones help proteins exploit their inbuilt folding potential and reach the correct three-dimensional structure. Researchers at the Max Planck Institute of Biochemistry (MPIB) have demonstrated that actin, the most abundant protein in higher developed cells, does not have the inbuilt potential to fold and instead requires special assistance to fold into its active state. The chaperone TRiC uses a previously undescribed mechanism to perform actin folding. The study was recently published in the journal Cell.

Actin is the most abundant protein in highly developed cells and has diverse functions in processes like cell stabilization, cell division and muscle...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

LaserForum 2018 deals with 3D production of components

17.08.2018 | Event News

Within reach of the Universe

08.08.2018 | Event News

A journey through the history of microscopy – new exhibition opens at the MDC

27.07.2018 | Event News

 
Latest News

Smallest transistor worldwide switches current with a single atom in solid electrolyte

17.08.2018 | Physics and Astronomy

Robots as Tools and Partners in Rehabilitation

17.08.2018 | Information Technology

Climate Impact Research in Hannover: Small Plants against Large Waves

17.08.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>